Adverse Outcomes Seen With MS Disease-Modifying Drugs in Pregnancy
Significant reductions seen in birth weight with exposure to certain DMTs, and increase seen in rate of small for gestational age
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.